Bio-Techne Is a Top S&P 500 Stock. Germany’s Merck Is Paying a 24% Premium for the Company.
Original Source
Read the full article at Barrons →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.